56 related articles for article (PubMed ID: 20071496)
1. Medication changes prior to hospitalization for obstructive lung disease: a case-crossover study.
Velthove KJ; Leufkens HG; Schweizer RC; van Solinge WW; Souverein PC
Ann Pharmacother; 2010 Feb; 44(2):267-73. PubMed ID: 20071496
[TBL] [Abstract][Full Text] [Related]
2. Measuring exacerbations in obstructive lung disease.
Velthove KJ; Souverein PC; van Solinge WW; Leufkens HG; Lammers JW
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):367-74. PubMed ID: 20014167
[TBL] [Abstract][Full Text] [Related]
3. Effects of corticosteroid use on readmission in obstructive lung disease.
Velthove KJ; Souverein PC; van Solinge WW; Leufkens HG; Lammers JW
Respir Med; 2010 Feb; 104(2):211-8. PubMed ID: 19781925
[TBL] [Abstract][Full Text] [Related]
4. Association between hospitalization and discontinuity of medication therapy used in the community setting in the Netherlands.
Stuffken R; Heerdink ER; de Koning FH; Souverein PC; Egberts AC
Ann Pharmacother; 2008 Jul; 42(7):933-9. PubMed ID: 18544655
[TBL] [Abstract][Full Text] [Related]
5. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study.
Handoko KB; Zwart-van Rijkom JE; Hermens WA; Souverein PC; Egberts TC
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):189-96. PubMed ID: 17036373
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study.
Roede BM; Bresser P; Bindels PJ; Kok A; Prins M; ter Riet G; Geskus RB; Herings RM; Prins JM
Thorax; 2008 Nov; 63(11):968-73. PubMed ID: 18682520
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
[TBL] [Abstract][Full Text] [Related]
8. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
[TBL] [Abstract][Full Text] [Related]
9. Identification of exacerbations in obstructive lung disease through biomarkers.
Velthove KJ; Bracke M; Souverein PC; Schweizer RC; Ten Berg MJ; Leufkens HG; van Solinge WW
Biomarkers; 2009 Nov; 14(7):523-8. PubMed ID: 19863191
[TBL] [Abstract][Full Text] [Related]
10. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
[TBL] [Abstract][Full Text] [Related]
11. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
14. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss.
Pouw EM; Ten Velde GP; Croonen BH; Kester AD; Schols AM; Wouters EF
Clin Nutr; 2000 Apr; 19(2):95-9. PubMed ID: 10867726
[TBL] [Abstract][Full Text] [Related]
15. Exposure to nonsteroidal anti-inflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study.
Insúa J; Mavros P; Hunsche E; Kong S; Tibaudin-Agver O
Am J Geriatr Pharmacother; 2006 Sep; 4(3):251-9. PubMed ID: 17062326
[TBL] [Abstract][Full Text] [Related]
16. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital.
Gibson PG; Wlodarczyk JH; Wilson AJ; Sprogis A
J Qual Clin Pract; 1998 Jun; 18(2):125-33. PubMed ID: 9631350
[TBL] [Abstract][Full Text] [Related]
19. [Discrepancy between the guidelines and practice by family physicians in treating adults with an exacerbation of asthma or chronic obstructive pulmonary disease].
Smeele IJ; Van Schayck CP; Van Den Bosch WJ; Van Den Hoogen HJ; Muris JW; Grol RP
Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2304-8. PubMed ID: 9864526
[TBL] [Abstract][Full Text] [Related]
20. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
